13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Biochemical Characterization of the α-l-Rhamnosidase DtRha from Dictyoglomus thermophilum : Application to the Selective Derhamnosylation of Natural Flavonoids

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          α- l-Rhamnosidases are catalysts of industrial tremendous interest, but their uses are still somewhat limited by their poor thermal stabilities and selectivities. The thermophilic DtRha from Dictyoglomus thermophilum was cloned, and the recombinant protein was easily purified to homogeneity to afford 4.5 mg/L culture of biocatalyst. Michaelis–Menten parameters demonstrated it to be fully specific for α- l-rhamnose. Most significantly, DtRha demonstrated to have a stronger preference for α(1 → 2) linkage rather than α(1 → 6) linkage when removing rhamnosyl moiety from natural flavonoids. This selectivity was fully explained by the difference of binding of the corresponding substrates in the active site of the protein.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Natural-product sugar biosynthesis and enzymatic glycodiversification.

          Many biologically active small-molecule natural products produced by microorganisms derive their activities from sugar substituents. Changing the structures of these sugars can have a profound impact on the biological properties of the parent compounds. This realization has inspired attempts to derivatize the sugar moieties of these natural products through exploitation of the sugar biosynthetic machinery. This approach requires an understanding of the biosynthetic pathway of each target sugar and detailed mechanistic knowledge of the key enzymes. Scientists have begun to unravel the biosynthetic logic behind the assembly of many glycosylated natural products and have found that a core set of enzyme activities is mixed and matched to synthesize the diverse sugar structures observed in nature. Remarkably, many of these sugar biosynthetic enzymes and glycosyltransferases also exhibit relaxed substrate specificity. The promiscuity of these enzymes has prompted efforts to modify the sugar structures and alter the glycosylation patterns of natural products through metabolic pathway engineering and enzymatic glycodiversification. In applied biomedical research, these studies will enable the development of new glycosylation tools and generate novel glycoforms of secondary metabolites with useful biological activity.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Building a More Predictive Protein Force Field: A Systematic and Reproducible Route to AMBER-FB15

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structural basis of kynurenine 3-monooxygenase inhibition

              Inhibition of kynurenine 3-monooxygenase (KMO), an enzyme in the eukaryotic tryptophan catabolic pathway (i.e. kynurenine pathway), leads to amelioration of Huntington’s disease-relevant phenotypes in yeast, fruit fly, and mouse models 1–5 , as well as a mouse model of Alzheimer’s disease 3 . KMO is a FAD-dependent monooxygenase, and is located in the outer mitochondrial membrane where it converts L-kynurenine to 3-hydroxykynurenine. Perturbations in the levels of kynurenine pathway metabolites have been linked to the pathogenesis of a spectrum of brain disorders 6 , as well as cancer 7,8 , and several peripheral inflammatory conditions 9 . Despite the importance of KMO as a target for neurodegenerative disease, the molecular basis of KMO inhibition by available lead compounds has remained hitherto unknown. Here we report the first crystal structure of KMO, in the free form and in complex with the tight-binding inhibitor UPF 648. UPF 648 binds close to the FAD cofactor and perturbs the local active site structure, preventing productive binding of the substrate kynurenine. Functional assays and targeted mutagenesis revealed that the active site architecture and UPF 648 binding are essentially identical in human KMO, validating the yeast KMO:UPF 648 structure as a template for structure-based drug design. This will inform the search for new KMO inhibitors that are able to cross the blood-brain barrier in targeted therapies against neurodegenerative diseases such as Huntington’s, Alzheimer’s, and Parkinson’s diseases.
                Bookmark

                Author and article information

                Journal
                ACS Omega
                ACS Omega
                ao
                acsodf
                ACS Omega
                American Chemical Society
                2470-1343
                24 January 2019
                31 January 2019
                : 4
                : 1
                : 1916-1922
                Affiliations
                []Université d’Orléans, CNRS, ICOA, UMR 7311 , Rue de Chartres, BP 6759, 45067 Orléans Cedex 2, France
                []Extrasynthese , CS 30062, ZI Lyon Nord, Impasse Jacquard, 69727 Genay Cedex, France
                Author notes
                Article
                10.1021/acsomega.8b03186
                6649072
                31459445
                f27c8a94-f55c-4057-bdc2-907ed0b85cd2
                Copyright © 2019 American Chemical Society

                This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

                History
                : 14 November 2018
                : 10 January 2019
                Categories
                Article
                Custom metadata
                ao8b03186
                ao-2018-03186y

                Comments

                Comment on this article